Cutaneous manifestations in patients of hepatitis C


  • Nadia Ali Azfar
  • Tariq Zaman
  • Tariq Rashid
  • Muhammad Jahangir


Hepatitis C, cutaneous, manifestation


Background Hepatitis C is a major public health problem, infecting 170 million people worldwide. It is associated with a number of extrahepatic manifestations, many of which are cutaneous. Objective The purpose of the study was to determine the nature and frequency of dermatological manifestations in hepatitis C virus (HCV) positive patients.  Patients and methods 371 HCV positive patients from the outpatient and inpatient departments of Jinnah hospital, Lahore were enrolled and evaluated for cutaneous manifestations. All the relevant data regarding history, clinical examination and investigations were recorded and analyzed.  Results Among all 371 cases cutaneous manifestations were present among 54%. Pruritus was the most common dermatological feature seen in 15.90% followed by palmar erythema 11.59% and lichen planus 7.82%.  Less common features were hyperpigmentation, cutaneous vasculitis, photosensitivity and urticaria. Pruritus, Schamberg’s disease and photosentivity were significantly more common in patients with antiviral therapy. 


Harden MD, Skelton H, Smith KJ. Lichen planus associated with hepatitis C virus: no viral transcripts are found in the lichen planus and effective therapy for hepatitis C does not clear lichen planus. J Am Acad Dermatol 2003; 49: 847-52.

Umar M, Bushra HT, Shuaib A et al. Spectrum of chronic liver disease due to hepatitis C virus infection. J Coll Physicians Surg Pak 2000; 10: 380-3

Khokhar N. Bone marrow suppression in chronic hepatitis C. Pak J Med Sci 2001; 17: 251-3.

Bovonsky HL, Mehta S. Hepatitis C a review and update. J Am Acad Dermatol 2001; 44: 159-79

Sterling JC. Viral infections. In: Burns T, Breathnach S, Cox N, Griffiths C, eds. Rook’s Textbook of Dermatology.7th edn. London: Blackwell Science; 2004. p. 25.1-83.

Aamir S, Ziaullah, Iqbal Z et al. Cutaneous manifestations of interferon alpha and ribavirin therapy for hepatitis C. J Pak Assoc of Dermatol 2008; 18: 14-20.

Cornelius LA, Lawley TJ. Cryoglobulinemia and cryofibrinogenimea. In: Freedberg IM, Eisen AZ, Wolff K et al., eds. Fitzpatrick’s Dermatology in General Medicine. 6th edn. New York: McGraw Hill; 2003. p. 1740-54.

Osella AR, Misciagna G, Leone A et al. Epidemiology of hepatitis C infection in an area of southern Italy. J Hepatol 1997; 27: 30-5.

Cacoub P, Renouc C, Rosenthal E et al. Extrahepatic manifestations associated with hepatitis C virus infection. Medicine (Baltimore) 2000; 79: 47-56.

Dega H, Frances C, Dupin N et al. Pruritus and the hepatitis C virus. Ann Dermatol Venereol 1998; 125: 9-12.

Beaird LM, Kabloon N, Franco J, Fairley JA. Screening of HCV in lichen planus patients. J Am Acad Dermatol 2001; 44: 311-2.

Chuang TY, Stitle L, Brashear R, Lewis C. Hepatitis C virus and lichen planus: A case control study of 340 patients. J Am Acad Dermatol 1999; 41: 787-9.

Tameez-ud-Deen, Naqqash S, Butt AQ. Lichen planus and hepatitis C virus infection : An epidemiologic study. J Pak Assoc Dermatol 2003; 13: 127-9.

Mahboob A, Haroon TS, Iqbal Z et al. Frequency of anti-HCV antibodies in patients with lichen planus. J Coll Physicians Surg Pak 2003; 13: 248-52.

Karlisberg PL, Le WM, Casey DL et al. Cutaneous vasculitis and rheumatoid factor positivity as presenting signs of hepatitis C virus induced mixed cryoglobulinemia. Arch Dermatol 1995; 131: 1119-23.

Dupin N, Chosidow O, Lunel F et al. Essential mixed cryoglobulinemia- comparative study of dermatological manifestations in patients infected or noninfected with hepatitis C virius. Arch Dermatol 1995; 131, 1424-7.

Pascual M, Perrin L, Giostra E, Schifferli JA. HCV in patients with Cryoglobulinemia type II. J Infec Dis 1990; 162: 569-70.

Cribier BJ, Santinelli F, Schimitt C et al. Chronic urticaria is not significantly associated hepatitis C or hepatitis G infection: A case-control study. Arch Dermatol 1999; 135: 1335-9.

Ahmed I, Wahid Z, Ahmed Z. Chronic urticaria: frequency of anti-HCV antibodies. J Pak Assoc Dermatol 2003; 13: 179-83.

Chuang TY, Stitle L, Brashear R, Lewis C. Porphyria cutanea tarda and hepatitis C virus: A case control study and meta-analysis of the literature. J Am Acad Dermatol 1999; 41: 31-6.

Neri S, Raciti C, D'Angelo G et al. Hyde's prurigo nodularis and chronic HCV hepatitis. J Hepatol 1998; 28: 161-4.

Sookolano S, Neglia V, Castano G et al. High prevalence of cutaneous reactions to interferon alpha plus ribavirin combination therapy in patients with chronic hepatitis C virus. Arch Dermatol 1999; 135: 1000-1.

Vazquez-Lopez F, Manjon-Haces JA, Perez-Alvarez, Perez-Oliva N. Eczema-like lesions and disruption of therapy in patients treated with interferon-alfa and ribavirin for chronic hepatitis C: the value of an interdisciplinary assessment. Br J of Dermatol 2004; 150: 1028-54.




How to Cite

Azfar NA, Zaman T, Rashid T, Jahangir M. Cutaneous manifestations in patients of hepatitis C. J Pak Assoc Dermatol [Internet]. 2016Dec.24 [cited 2024Feb.26];18(3):138-43. Available from:



Original Articles

Most read articles by the same author(s)

1 2 3 4 5 6 > >>